Showing results (71-80 of 427) with videos related to

Sort By:
Pageof 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2016
Obesity and Cancer Mechanisms: Tumor Microenvironment and InflammationNeil M Iyengar, Ayca Gucalp, Andrew J Dannenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2013
Molecular pathways: adipose inflammation as a mediator of obesity-associated cancerLouise R Howe, Kotha Subbaramaiah, Clifford A Hudis, et al.
Physical Review Letters|March 21, 2008
Spin resonance in the d-wave superconductor CeCoIn5C Stock, C Broholm, J Hudis, et al.
The Journal of Biological Chemistry|December 18, 2007
EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchangeKotha Subbaramaiah, Clifford Hudis, Sung-Hee Chang, et al.
Clinical Breast Cancer|May 13, 2009
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancerMaria Theodoulou, Gerald Batist, Susana Campos, et al.
Breast Cancer Research and Treatment|March 12, 2011
Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi WomenE Comen, M Davids, T Kirchhoff, et al.
Critical Reviews in Oncology/Hematology|April 25, 2003
Factors influencing treatment patterns of breast cancer patients age 75 and olderArti Hurria, Denis Leung, Kathleen Trainor, et al.
Cancer|September 1, 2005
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxaneMonica N Fornier, Shanu Modi, Katherine S Panageas, et al.
American Journal of Clinical Pathology|May 21, 2004
HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: a single-institution experience of 2,279 cases and comparison of dual-color and single-color scoringPriti Lal, Paulo A Salazar, Clifford A Hudis, et al.
Mutation Research|December 17, 2008
cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutationLiying Zhang, Ruben Bacares, Sherry Boyar, et al.
Pageof 43